Correlation Between LMF Acquisition and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both LMF Acquisition and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LMF Acquisition and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LMF Acquisition Opportunities and Revelation Biosciences, you can compare the effects of market volatilities on LMF Acquisition and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LMF Acquisition with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of LMF Acquisition and Revelation Biosciences.
Diversification Opportunities for LMF Acquisition and Revelation Biosciences
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between LMF and Revelation is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding LMF Acquisition Opportunities and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and LMF Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LMF Acquisition Opportunities are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of LMF Acquisition i.e., LMF Acquisition and Revelation Biosciences go up and down completely randomly.
Pair Corralation between LMF Acquisition and Revelation Biosciences
Considering the 90-day investment horizon LMF Acquisition Opportunities is expected to generate 0.76 times more return on investment than Revelation Biosciences. However, LMF Acquisition Opportunities is 1.32 times less risky than Revelation Biosciences. It trades about -0.01 of its potential returns per unit of risk. Revelation Biosciences is currently generating about -0.11 per unit of risk. If you would invest 200.00 in LMF Acquisition Opportunities on December 28, 2024 and sell it today you would lose (30.00) from holding LMF Acquisition Opportunities or give up 15.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
LMF Acquisition Opportunities vs. Revelation Biosciences
Performance |
Timeline |
LMF Acquisition Oppo |
Revelation Biosciences |
LMF Acquisition and Revelation Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with LMF Acquisition and Revelation Biosciences
The main advantage of trading using opposite LMF Acquisition and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LMF Acquisition position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.LMF Acquisition vs. ZyVersa Therapeutics | LMF Acquisition vs. Sonnet Biotherapeutics Holdings | LMF Acquisition vs. Revelation Biosciences | LMF Acquisition vs. Quoin Pharmaceuticals Ltd |
Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |